首页> 外国专利> medicine for causal treatment of skin disease 'atopic dermatitis (dermatitis vasculosa) in the form of a percutaneous applizierbaren salbenpru00e4parates

medicine for causal treatment of skin disease 'atopic dermatitis (dermatitis vasculosa) in the form of a percutaneous applizierbaren salbenpru00e4parates

机译:皮肤病的因果治疗药物“特应性皮炎(vastitis vasculosa)”以经皮贴敷的形式出现

摘要

medicine for causal treatment of skin disease u201eneurodermitis (dermatitis vasculosa) in the form of a percutaneous applizierbaren salbenpru00e4parates,characterized by the fact thatthe following active substances as main components in the ointment are included, which are capable of causing the autosomal dominant inherited skin disease u201eneurodermitis (dermatitis vasculosa), identifiable as generalised kapillargefu00e4u00dfmuskulaturspastik what the main symptoms pruritus and dermographia alba, which eliminatewith special intention isthe number of the components of the medicine (ointment) in only a few (a maximum of 20 agents) to limit the u201eneurodermitis (dermatitis vasculosa) persons often allergy and allergieneubildung tend (antibody against new substances), and in two need to check the necessary allergy testing substances able to see.1. muskulotropes vasospasmolytikum, at the same time as antipruriginosum: (only peripherally (capillary) effective) papaverin, & br / & moxaverin.2.antihistamin: dimetinden & br / & & br / & homeopathic substances: & br / & loofah operculata mixing. d4 & br / & galphimia glauca mixing. d3 & br / & cardiospermum d33.lokalanu00e4sthetikum: lidocain4.anti-inflammatory drug; phytopharmaceuticals; & br / & plant extracts & br / & arnica & br / & propolis & br / & fenchel5.dermatoregenerativum: zink6.thermoregulans, at the same time antipruriginosum: menthol
机译:因果治疗皮肤病的药物 u201神经皮炎(皮炎)事实是包含以下作为软膏主要成分的活性物质,它们能够引起常染色体显性遗传性皮肤病,皮疹,血管炎,皮疹,皮肤瘙痒等主要症状。有特殊意图的是药物的成分(药膏)的数量很少(最多20种),以限制神经皮炎(血管炎)的人经常出现过敏和变态反应神经病倾向(针对新物质的抗体),而在两种情况下需要检查能够看到的必要的过敏测试物质。1. muskulotropes vasospasmolytikum,与antipruriginosum同时使用:(仅对外周(毛细血管)有效)罂粟碱,< br /& Moxaverin.2.antihistamin:dimetinden& br /& & br /&顺势疗法物质: br /&丝瓜络混合。 d4& br /&青冈混合。 d3& br /& Cardiospermum d33.lokalan sthetikum:利多卡因4.抗炎药;植物药物; & br /&植物提取物br /&阿尼卡& br /&蜂胶br /& fenchel5.dermatoregenerativum:zink6.thermoregulans,同时抗pruriginosum:薄荷醇

著录项

  • 公开/公告号DE202015003712U8

    专利类型

  • 公开/公告日2015-10-15

    原文格式PDF

  • 申请/专利权人 EBISAN JOSEPH PRINCE AFINI-AWANI;

    申请/专利号DE202015003712U8

  • 发明设计人

    申请日2015-05-21

  • 分类号A61K31/472;A61K31/4402;A61K35/644;A61K31/167;A61K36/28;A61K36/235;A61K31/045;A61P17/04;A61P17/00;A61P37/00;

  • 国家 DE

  • 入库时间 2022-08-21 14:54:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号